Showing results (61-70 of 1,274) with videos related to

Sort By:
Pageof 128
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 20, 2019
An unusual cause of recurrent mitral regurgitation after percutaneous mitral valve repairMirjam Gauri Winkel, Nicolas Brugger, Stephan Windecker, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 3, 2021
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE TrialJuan F Iglesias, Dik Heg, Marco Roffi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 7, 2016
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trialAnna Franzone, Masanori Taniwaki, Fabio Rigamonti, et al.
Circulation|August 8, 2007
Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurementsPascal Meier, Steffen Gloekler, Rainer Zbinden, et al.
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 28, 2010
Sirolimus versus paclitaxel coronary stents in clinical practiceNiklas Millauer, Peter Jüni, Alexandra Hofmann, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|December 20, 2021
Left ventricular thrombus in ischaemic heart disease: diagnosis, treatment, and gaps of knowledgeLudovic Allard, Benedikt Bernhard, Stephan Windecker, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 31, 2018
Current state of alternative access for transcatheter aortic valve implantationJonas Lanz, Adam Greenbaum, Thomas Pilgrim, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 21, 2019
Evolving paradigms in valvular heart disease: where should guidelines move?Andreas Baumbach, Dariusz Dudek, Helmut Baumgartner, et al.
Pageof 128